Search Results

Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena.

• Authors : AlAnazi, Faisal Holil; Al‐kuraishy, Hayder M.; Al‐Gareeb, Ali I.

Subjects: NEPRILYSIN; TYPE 2 diabetes; GLUCAGON-like peptide 1

• Source: Journal of Diabetes; May2023, Vol. 15 Issue 5, p397-408, 12p

Record details

Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with β-cell dysfunction.

• Authors : Esser, Nathalie; Mongovin, Stephen M.; Parilla, Jacqueline

Subjects: NEPRILYSIN; INSULIN receptors; ANGIOTENSIN-receptor blockers

• Source: American Journal of Physiology: Endocrinology & Metabolism; Mar2022, Vol. 322 Issue 3, p307-318, 12p

Record details

Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes.

• Authors : Wewer Albrechtsen, Nicolai J.; Møller, Andreas; Martinussen, Christoffer

Subjects: TYPE 2 diabetes; INSULIN; NEPRILYSIN

• Source: Diabetes, Obesity & Metabolism; Oct2022, Vol. 24 Issue 10, p2017-2026, 10p

Record details

Neprilysin deficiency reduces hepatic gluconeogenesis in high fat-fed mice.

• Authors : Esser, Nathalie^1,2,3 (AUTHOR); Mongovin, Stephen M.¹ (AUTHOR); Mundinger, Thomas O.² (AUTHOR)

Subjects: *NEPRILYSIN; *INSULIN; *GLUCONEOGENESIS

• Source: Peptides. Oct2023, Vol. 168, pN.PAG-N.PAG. 1p.

Record details

Neprilysin expression and functions in development, ageing and disease.

• Authors : Nalivaeva, NN^1,2 (AUTHOR) ; Zhuravin, IA¹ (AUTHOR); Turner, AJ² (AUTHOR)

Subjects: NEPRILYSIN; AGE factors in disease; TYPE 2 diabetes

• Source: Mechanisms of Ageing & Development. Dec2020, Vol. 192, pN.PAG-N.PAG. 1p.

Record details

Impact of the angiotensin receptor‐neprilysin inhibitor in clinical diabetes management: Potential benefits and pitfalls.

• Authors : Kato, Tomoko; Murakami, Takaaki; Yabe, Daisuke

Subjects: HEART failure; ANGIOTENSINS; HEALTH services administration

• Source: Journal of Diabetes Investigation; Sep2023, Vol. 14 Issue 9, p1038-1040, 3p

Record details

Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.

• Authors : Schumacher, Christine

Subjects: HEART failure treatment; DRUG efficacy; DIURETICS

• Source: Journal of Pharmacy Practice; Apr2024, Vol. 37 Issue 2, p495-499, 5p

Record details

Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

• Authors : Esser, Nathalie; Zraika, Sakeneh

• Source: Diabetologia; Jul2019, Vol. 62 Issue 7, p1113-1122, 10p, 2 Diagrams, 2 Charts

Record details

Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes.

• Authors : Sardu, Celestino; Marfella, Ludovica Vittoria; Giordano, Valerio

Subjects: TYPE 2 diabetes; CARDIAC pacing; NEPRILYSIN

• Source: Frontiers in Pharmacology; 2024, p1-10, 10p

Record details

Augmentation of glucagon-like peptide-1 receptor signalling by neprilysin inhibition: potential implications for patients with heart failure.

• Authors : Packer, Milton

Subjects: GLUCAGON-like peptide-1 receptor; TYPE 2 diabetes; NEPRILYSIN

• Source: European Journal of Heart Failure; Jun2018, Vol. 20 Issue 6, p973-977, 5p, 1 Diagram

Record details